A novel multipatient intranasal diamorphine spray for use in acute pain in children: pharmacovigilance data from an observational study
نویسندگان
چکیده
OBJECTIVES To establish the safety of an intranasal diamorphine (IND) spray in children. DESIGN An open-label, single-dose pharmacovigilance trial. SETTING Emergency departments in eight UK hospitals. PARTICIPANTS Children aged 2-16 years with a fracture or other trauma. OUTCOME MEASURES Adverse events (AE) specifically related to nasal irritation, respiratory and central nervous system depression. RESULTS 226 patients received 0.1 mg/kg IND. No serious or severe AEs occurred. The incidence of treatment-emergent AEs (TEAEs) was 26.5% (95% CI 20.9% to 32.8%), 93% being mild. 89% were related to treatment, all being known effects of the drug or route of administration except for three events in two patients. 20.4% (95% CI 15.3% to 26.2%) patients reported nasal irritation, all mild except one moderate and one 'unknown' severity. No respiratory depression was reported. Three AEs related to reduced Glasgow Coma Score (GCS) occurred, all mild. CONCLUSIONS There were no safety concerns raised during the conduct of the study. In addition to expected side effects, IND can cause mild nasal irritation in a proportion of patients. EUROPEAN UNION DRUG REGULATING AUTHORITIES CLINICAL TRIAL NO 2009-014982-16.
منابع مشابه
Hannah Skuse and Vanessa Lawlor consider methods and outcomes of analgesia among children experiencing pain after severe injuries intranasal DiaMorpHine in cHilDren WitH trauMa
Best practice in treating children in severe acute pain, according to the college of emergency Medicine children’s pain assessment tool (2010), is to administer intravenous (iV) morphine or intranasal diamorphine. this article discusses the intranasal delivery of analgesia, which according to Kidd et al (2009) is less traumatic than the potentially difficult and distressing iV route. a survey o...
متن کاملIntranasal diamorphine for paediatric analgesia: assessment of safety and efficacy.
OBJECTIVE To evaluate the safety and efficacy of intranasal diamorphine as an analgesic for use in children in accident and emergency (A&E). METHODS A prospective, randomised clinical trial with consecutive recruitment of patients aged between 3 and 16 years with clinically suspected limb fractures. One group received 0.1 mg/kg intranasal diamorphine, and the other group received 0.2 mg/kg in...
متن کاملMulticentre randomised controlled trial of nasal diamorphine for analgesia in children and teenagers with clinical fractures.
OBJECTIVE To compare the effectiveness of nasal diamorphine spray with intramuscular morphine for analgesia in children and teenagers with acute pain due to a clinical fracture, and to describe the safety profile of the spray. DESIGN Multicentre randomised controlled trial. SETTING Emergency departments in eight UK hospitals. PARTICIPANTS Patients aged between 3 and 16 years presenting wi...
متن کاملIntranasal Drug Delivery for Children with Acute Illness
Management of pain and anxiety for children requiring urgent care has progressed dramatically in the past decade. However, the administration of analgesia and sedation in children is inconsistent, with significant practice variation among practitioners, and especially amid younger children who receive less than optimal analgesia. Nasal administrations of drugs have several significant advantage...
متن کاملManagement of breakthrough pain in children with cancer
Breakthrough pain in children with cancer is an exacerbation of severe pain that occurs over a background of otherwise controlled pain. There are no randomized controlled trials in the management of breakthrough pain in children with cancer, and limited data and considerable experience indicate that breakthrough pain in this pediatric patient group is common, underassessed, and undertreated. An...
متن کامل